Rebus Biosystems

About:

Rebus Biosystems is a life science technology company creating revolutionary tools to enable spatial omics research without compromise.

Website: https://rebusbio.com/

Top Investors: Illumina Ventures, Timepolio Asset Management, LabGenomics, CTK Investments, NCore Ventures

Description:

Rebus Biosystems is a venture-backed Silicon Valley-based life science technology company creating revolutionary tools to enable spatial omics research without compromise. The company’s first instrument, the Rebus Esper, is a fully integrated, automated spatial omics platform that delivers quantitative single molecule, single-cell data with subcellular resolution. Advanced imaging, on-system chemistry, and intuitive software have been combined to provide an end-to-end solution requiring minimal hands-on time. Rebus Biosystems provides all-inclusive assay kits to empower researchers with the resolution, scale and speed of the Rebus Esper for multiple applications. Learn more at www.rebusbio.com.

Total Funding Amount:

$37.8M

Headquarters Location:

Santa Clara, California, United States

Founded Date:

2006-01-01

Founders:

Josh Ryu

Number of Employees:

11-50

Last Funding Date:

2022-11-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai